Rare diseases
Investigational molecules
Locations
Back to France2 221 clinical trials in Lyon, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Atezolizumab Combined with Radiotherapy in Patients with Operable Soft Tissue Sarcomas
FranceStudy on Stopping and Restarting Acalabrutinib in Elderly Patients with Untreated Chronic Lymphocytic Leukemia (CLL)
FranceStudy Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer
FranceStudy on the Safety and Effectiveness of Azacitidine and Venetoclax for Untreated Higher-Risk Myelodysplastic Syndromes Not Eligible for Transplant
FranceStudy on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib
FranceStudy of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis
FranceStudy of ODM-208 (opevesostat) safety and effectiveness in patients with metastatic castration-resistant prostate cancer
FranceStudy of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease
FranceStudy of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions
FranceStudy on the Effects of Povetacicept for Adults with IgA Nephropathy
FranceStudy on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema
FranceStudy on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for endometrial carcinoma, bladder cancer, and various solid tumors. Current research explores combination therapies with novel immunotherapy approaches.
Multiple studies are evaluating targeted therapies and immunological approaches for various tumor types.
Groundbreaking research in immune system modulation and infectious disease prevention, including studies on COVID-19 vaccines and immune response in critical conditions.
Focus on developing innovative vaccination strategies and immune system interventions.
Studies addressing long-term health conditions, with particular emphasis on kidney disease, cardiovascular health, and metabolic disorders.
Innovative approaches combining established and experimental treatments for improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
